[{"NetIncomeLoss_1_Q3_USD":17139000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":5890000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.8424,"InterestPaidNet_3_Q3_USD":1165000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":237000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.0162,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-15203000.0,"DebtInstrumentInterestRateDuringPeriod_3_Q3_pure":0.0808,"DebtInstrumentInterestRateDuringPeriod_1_Q3_pure":0.0807,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":266724.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":314000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":292298000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-558000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9079000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":108000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-161000.0,"EquitySecuritiesFvNi_0_Q3_USD":78872000.0,"CommonStockSharesIssued_0_Q3_shares":38092978.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":201883000.0,"Assets_0_Q3_USD":307237000.0,"ShareBasedCompensation_3_Q3_USD":8830000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":8473259.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":108250000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":5.09,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":5.69,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-823000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":72000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":26435000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_1_Q3_USD":19361000.0,"EarningsPerShareBasic_3_Q3_USD":0.91,"EarningsPerShareBasic_1_Q3_USD":0.46,"InterestPayableCurrentAndNoncurrent_0_Q3_USD":200000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":78638000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":29778000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30349856.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":37877552.0,"ProceedsFromStockPlans_3_Q3_USD":1285000.0,"AccountsReceivableNetCurrent_0_Q3_USD":7483000.0,"CommonStockValue_0_Q3_USD":38000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3125000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-127000.0,"MarketableSecuritiesCurrent_0_Q3_USD":137990000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":124393000.0,"InvestmentIncomeNonoperating_3_Q3_USD":1320000.0,"InvestmentIncomeNonoperating_1_Q3_USD":295000.0,"IncreaseDecreaseInDeferredCharges_3_Q3_USD":129000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":27488000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":16978000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-716000.0,"OtherAssetsNoncurrent_0_Q3_USD":2122000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":64370000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":412173000.0,"Liabilities_0_Q3_USD":63118000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q3_shares":8890.0,"RevenueFromRelatedParties_3_Q3_USD":2813000.0,"RevenueFromRelatedParties_1_Q3_USD":0.0,"ProceedsFromIssuanceOfDebt_3_Q3_USD":25000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":34444000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":17823000.0,"OperatingIncomeLoss_3_Q3_USD":-46214000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":314000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3112000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-48923000.0,"RepaymentsOfDebt_3_Q3_USD":10000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29994917.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":36887266.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":29910000.0,"AccountsPayableCurrent_0_Q3_USD":4879000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":65242000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3583000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.7315,"ProceedsFromStockOptionsExercised_3_Q3_USD":172000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":237000.0,"LongTermDebtNoncurrent_0_Q3_USD":24411000.0,"InterestExpenseDebt_1_Q3_USD":700000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3_Q3_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q3_USD":0.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":65242000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.0016,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":191153.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":639000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":11000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11945000.0,"NetIncomeLoss_3_Q3_USD":27416000.0,"InterestExpenseDebt_3_Q3_USD":1700000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":113999000.0,"RestrictedCashNoncurrent_0_Q3_USD":872000.0,"EarningsPerShareDiluted_1_Q3_USD":0.45,"OperatingIncomeLoss_1_Q3_USD":-10617000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":129000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":48000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":15703000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":307237000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8830000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3112000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":300000.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":100000.0,"OperatingExpenses_3_Q3_USD":80658000.0,"OperatingExpenses_1_Q3_USD":28440000.0,"ProfitLoss_3_Q3_USD":27416000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":151000.0,"OtherLiabilitiesCurrent_0_Q3_USD":3438000.0,"StockholdersEquity_0_Q3_USD":244119000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":8366000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":201646000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-293000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":280000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-747000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":66681.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-168329000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":60267000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":1185000.0,"CommonStockSharesOutstanding_0_Q3_shares":38092978.0,"EarningsPerShareDiluted_3_Q3_USD":0.9,"ResearchAndDevelopmentExpense_3_Q3_USD":54223000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-11591000.0,"Ticker":"STRO","CIK":"1382101","name":"SUTRO BIOPHARMA, INC.","OfficialName":"Sutro Biopharma Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"326059920.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]